M&A · Healthcare · Pharmaceutical Preparations
MediPacific, Inc. to acquire Pardes Biosciences, Inc.
Announced Jul 17, 2023 · Closed Aug 31, 2023
Deal value—
Premium17.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- MediPacific, Inc.
- Target
- Pardes Biosciences, Inc. (PRDS)
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Aug 31, 2023
Deal protections
- Break fee (target pays)
- $2.6M
- Reverse fee (buyer pays)
- —
- Go-shop
- No-shop
- Financing
- No financing condition
Advisors
- To the acquirer
- Not disclosed
- To the target
- Leerink Partners
Sector context · Healthcare
- Comparable deals
- 87 in the prior 24 months
- Premium
- 17.0% vs. 50.0% sector median
- EV / Adj. EBITDA
- Sector median 17.4x
- Break fee
- Sector median 3.5%
Timeline
- AnnouncedJul 17, 2023
- Tender offerJul 28, 2023
- ClosedAug 31, 2023